Fellowship Program Description
The first year of the program is an intensive training period in clinical hematology/oncology/stem cell transplantation. The second and third years are dedicated primarily to laboratory research. Previous substantive research experience is very helpful. Applicants to the program will be expected to have completed a pediatric residency program approved by the Accreditation Council for Graduate Medical Education (ACGME). Two years of ACGME residency training in the United States or Canada is required for a California Medical License. Applicants who match with a California fellowship training program should apply for a California Medical License at least nine (9) months in advance of the fellowship start date. It takes a minimum of nine (9) months to obtain a California Medical License. You must have a California medical license prior to the starting date of your fellowship (July 1).
Due to NIH funding restrictions, all applicants must be either United States citizens or have permanent resident status in the United States by the beginning date of their fellowship training. There are no exceptions. The program is unable to support or sponsor H1B visas.
All fellows must be funded through the Division of Pediatric Hematology/Oncology/Stem Cell Transplanation/Cancer Biology. The School of Medicine does not allow self-funded fellows.
Fellowship Program Recruitment
We participate in the fellowship match sponsored by the National Resident Matching Program (NRMP) in coordination with the Accreditation Council for Graduate Medical Education (ACGME).
Our Pediatric Hematology/Oncology subspecialty program participates in the Electronic Residency Application Service (ERAS). Applications for fellowship positions should be submitted through ERAS http://www.aamc.org/audienceeras.htm starting in November of the year prior to the fellowship match (two years prior to the expected fellowship start date.) Please try to have all application materials submitted within 30 days, ideally by mid-December. Applications received through ERAS will be reviewed by the application review committee and those applicants selected for an interview will be sent an invitation to interview. Interviews will most likely be held from January through March.
Applicants should apply electronically through ERAS and provide all the requested documents through ERAS -- no other materials need to be submitted to our program separately. Please be informed that the program is unable to support or sponsor H-1B Visas.
International Medical Graduate applicants should provide a copy of their Educational Commission for Foreign Medical Graduates (ECFMG) certificate. The ECFMG website is http://www.ecfmg.org/ for more information. International Medical Graduate applicants must have completed 2 years of ACGME training (Accreditation Council for Graduate Medical Education training) in a U.S. residency program prior to beginning a fellowship. This is a requirement because two years of ACGME residency training in the United States or Canada is required for a California Medical License. The program accepts applications of J-1 Visas sponsored by the ECFMG.
Any physicians who work in the state of California are required to have a California Medical License. If you should match with a fellowship program in the state of California, then you will need to apply for a California medical license. It takes 9 months to receive a California license after the submission of a California license application. Please visit http://www.medbd.ca.gov/ for more information about the Medical Board of California.
Program Inquiries
Inquiries regarding fellowship applications can be directed to:
Fellowship Program Coordinator
Annamarie Coelho [amcoelho]
Phone: (650) 723-5535
FAX : (650) 723-5231
Our academic office is located at:
Stanford University School of Medicine
Division of Pediatric Hematology/Oncology/Stem Cell
Transplantation/Cancer Biology
(Mail Code 5798)
1000 Welch Road, Suite 300
Palo Alto , CA 9430
Phone: (650) 723-5535
FAX: (650) 723-5231.
Fellowship Program Director
- Kathleen Sakamoto, MD, PhD – Fellowship Program Director (link Sakamoto’s cap code to name)
- Arun Rangaswami, MD – Associate Program Director (Clinical)
- Alejandro Sweet-Cordero, MD - Associate Program Director (Research)
Clinical Program
Our training program consists of twenty-five full-time faculty. Within our program, 3 Fellows are accepted every year. There are active programs covering a broad range of modern cancer patient care and clinical and laboratory research.
Educational Component
The educational program is supported by a wide variety of educational conferences, lectures, journal clubs, and required classes.
- Educational Series/Board Review (weekly - required)
- Pediatric Tumor Board (weekly - required)
- Journal Club (monthly - required)
- Research Conference (monthly - required)
- Daily didactic lecture (first month of fellowship – required for first year trainees)
- Inpatient Rounds (daily – required during the Inpatient blocks)
- Bereavement Rounds (monthly-optional; required when fellow’s patient is discussed)
- Morbidity & Mortality Conference (quarterly - required; substitutes for Pediatric Tumor Board
- Pediatric Neuro-Oncology Tumor Board (weekly – optional; required during Neuro-Oncology Consult blocks)
Clinical Training Component (Year 1)
The clinical training year is structured into 13 four-week blocks as follows:
- 4 blocks of Inpatient Hematology/Oncology/Stem Cell Transplantation
- 3 blocks of Hematology Consult
- 2 blocks of Stem Cell Transplantation
- 2 blocks Oncology Consult
- 1 block Lab & Transfusion Medicine/ Hematopathology
- 1 block of Neuro-Oncology Consult
During the year, fellows receive four weeks of vacation, taken one week at a time during the outpatient months.
Please go to the “Clinical TrainingYear” tab for additional information on fellowship responsibilities.
